- Home
- AXSM vs GGAL Comparison
AXSM vs GGAL Comparison
Compare AXSM & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- GGAL
- Stock Information
- Founded
- AXSM 2012
- GGAL 1905
- Country
- AXSM United States
- GGAL Argentina
- Employees
- AXSM N/A
- GGAL N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- GGAL Commercial Banks
- Sector
- AXSM Health Care
- GGAL Finance
- Exchange
- AXSM Nasdaq
- GGAL Nasdaq
- Market Cap
- AXSM 5.1B
- GGAL 10.0B
- IPO Year
- AXSM 2015
- GGAL N/A
- Fundamental
- Price
- AXSM $105.00
- GGAL $51.01
- Analyst Decision
- AXSM Strong Buy
- GGAL Strong Buy
- Analyst Count
- AXSM 17
- GGAL 4
- Target Price
- AXSM $171.65
- GGAL $59.00
- AVG Volume (30 Days)
- AXSM 649.3K
- GGAL 1.6M
- Earning Date
- AXSM 08-04-2025
- GGAL 01-01-0001
- Dividend Yield
- AXSM N/A
- GGAL 3.23%
- EPS Growth
- AXSM N/A
- GGAL 29.31
- EPS
- AXSM N/A
- GGAL 0.85
- Revenue
- AXSM $432,157,000.00
- GGAL $5,277,001,683.00
- Revenue This Year
- AXSM $62.84
- GGAL $2.91
- Revenue Next Year
- AXSM $60.02
- GGAL N/A
- P/E Ratio
- AXSM N/A
- GGAL $6.32
- Revenue Growth
- AXSM 72.16
- GGAL N/A
- 52 Week Low
- AXSM $72.21
- GGAL $23.53
- 52 Week High
- AXSM $139.13
- GGAL $74.00
- Technical
- Relative Strength Index (RSI)
- AXSM 47.99
- GGAL 36.57
- Support Level
- AXSM $102.26
- GGAL $49.26
- Resistance Level
- AXSM $106.35
- GGAL $52.65
- Average True Range (ATR)
- AXSM 3.09
- GGAL 1.82
- MACD
- AXSM 0.15
- GGAL -0.13
- Stochastic Oscillator
- AXSM 66.44
- GGAL 20.92
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.